The role of healthtech and AI in cancer treatment

Artificial intelligence (AI) is rapidly transforming the landscape of oncology–from the earliest stages of drug discovery to the realities of clinical care.

In this edition of DayOne's Open Mic: Next in Health event series, we invite you to explore this evolving frontier through a multidisciplinary panel discussion featuring experts from data science, computational biology and clinical oncology.

Together, we’ll trace the journey of innovation across three critical domains:

• Multimodal drug discovery: How AI is accelerating the identification of novel therapeutic targets and compounds by integrating diverse data types.
• Clinical trial optimization: How machine learning is being used to design smarter trials, improve patient stratification, and reduce time to insight.
• Clinical integration: How hospitals are adopting AI-driven tools to support oncologists in diagnosis, treatment planning, and personalized care delivery.

Expect a candid and forward-looking conversation on the opportunities, challenges and ethical considerations of embedding AI into the oncology pipeline–from bench to bedside. Our panelists are:

• Caoimhe Vallely-Gilroy, Director, DayOne (Moderator)
• Manish Khatri, Director, Clinical Science Data & AI Lead – Oncology Portfolio, Novartis
• Tim Heinemann, Computational Biologist, CSEM
• Benjamin Kasenda, Senior Consultant Medical Oncologist, University Hospital Basel

Whether you’re a healthcare innovator, clinician, researcher or policymaker, this session will offer valuable insights into what’s next in cancer care. Register early to avoid missing out!

Participation is free; however, registration is required before 8 Sep 2025 (onsite). A livestream will be available.